A role for the transcription factor HEY1 in glioblastoma

Journal of Cellular and Molecular Medicine

Volumn 13, Issue 1, 2009, Pages 136-146

  Hulleman, Esther ^a,h   Quarto, Micaela ^b   Vernell, Richard ^a   Masserdotti, Giacomo ^a   Colli, Elena ^a   Kros, Johan M ^c   Levi, Daniel ^d   Gaetani, Paolo ^d   Tunici, Patrizia ^e   Finocchiaro, Gaetano ^e   Baena, Riccardo Rodriguez ^d   Capra, Maria ^d   Helin, Kristian ^a,f,g  

^a EUROPEAN INSTITUTE OF ONCOLOGY   (Italy)

^b FIRC INSTITUTE OF MOLECULAR ONCOLOGY   (Italy)

^c ERASMUS MEDICAL CENTER   (Netherlands)

^d HUMANITAS CLINICAL AND RESEARCH CENTER   (Italy)

^e DEPARTMENT OF NEUROSURGERY   (Italy)

^f UNIVERSITY OF COPENHAGEN   (Denmark)

^g UNIVERSITY OF COPENHAGEN   (Denmark)

^h SOPHIA CHILDREN S HOSPITAL   (Netherlands)

Author keywords

E2F; Glioblastoma; HEY1; Molecular marker; Notch; RNA interference

Indexed keywords

BASIC HELIX LOOP HELIX TRANSCRIPTION FACTOR; CELL CYCLE PROTEIN; HEY1 PROTEIN, HUMAN; NOTCH RECEPTOR; TRANSCRIPTION FACTOR E2F;

ANIMAL; ARTICLE; BRAIN TUMOR; C57BL MOUSE; CELL LINE; CELL PROLIFERATION; DISEASE COURSE; GENETICS; GLIOBLASTOMA; HUMAN; METABOLISM; MOUSE; PATHOLOGY; PHYSIOLOGY; RNA INTERFERENCE; SIGNAL TRANSDUCTION; TISSUE MICROARRAY;

ANIMALS; BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; BRAIN NEOPLASMS; CELL CYCLE PROTEINS; CELL LINE; CELL PROLIFERATION; DISEASE PROGRESSION; E2F TRANSCRIPTION FACTORS; GLIOBLASTOMA; HUMANS; MICE; MICE, INBRED C57BL; RECEPTORS, NOTCH; RNA INTERFERENCE; SIGNAL TRANSDUCTION; TISSUE ARRAY ANALYSIS;

EID: 58649120268     PISSN: 15821838     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1582-4934.2008.00307.x     Document Type: Article

References (57)

1. Nakano I, Kornblum HI. Brain tumor stem cells. Pediatr Res. 2006 59 : 54R 8R.
2. Hulleman E, Helin K. Molecular mechanisms in gliomagenesis. In : Klein G vande Woude GF, editors. Advances in cancer research 94. San Diego, CA : Elsevier Academic Press 2005. 1 27.
3. Sanai N, Alvarez-Buylla A, Berger MS. Neural stem cells and the origin of gliomas. N Engl J Med. 2005 353 : 811 22.
4. Nicolis SK. Cancer stem cells and "stemness" genes in neuro-oncology. Neurobiol Dis. 2007 25 : 217 29.
5. Okano H. Stem cell biology of the central nervous system. J Neurosci Res. 2002 69 : 698 707.
6. Thomas CY, Chouinard M, Cox M, Parsons S, Stallings-Mann M, Garcia R, Jove R, Wharen R. Spontaneous activation and signaling by overexpressed epidermal growth factor receptors in glioblastoma cells. Int J Cancer. 2003 104 : 19 27.
7. Ramnarain DB, Park S, Lee DY, Hatanpaa KJ, Scoggin SO, Out H, Libermann TA, Raisanen JM, Ashfaq R, Wong ET, Wu J, Elliott R, Habib AA. Differential gene expression analysis reveals generation of an autocrine loop by a mutant epidermal growth factor receptor in glioma cells. Cancer Res. 2006 66 : 867 74.
8. Ohgaki H, Kleihues P. Genetic pathways to primary and secondary glioblastoma. Am J Pathol. 2007 170 : 1445 53.
9. Artavanis-Tsakonas S, Rand MD, Lake RJ. Notch signaling: cell fate control and signal integration in development. Science 1999 284 : 770 6.
10. Bray SJ. Notch signaling: a simple pathway becomes complex. Nat Rev Mol Cell Biol. 2006 7 : 678 89.
11. Fisher A, Caudy M. The function of hairyrelated bHLH repressor proteins in cell fate decisions. Bioessays. 1998 20 : 298 306.
12. Iso T, Kedes L, Hamamori Y. HES and HERP families: multiple effectors of the Notch signaling pathway. J Cell Physiol. 2003 194 : 237 55.
13. Ohtsuka T, Ishibashi M, Gradwohl G, Nakanishi S, Guillemot F, Kageyama R. Hes1 and Hes5 as notch effectors in mammalian neuronal differentiation. EMBO J. 1999 18 : 2196 207.
14. Sakamoto M, Hirata H, Ohtsuka T, Bessho Y, Kageyama R. The bHLH genes Hesr/Hey1 and Hesr2/Hey2 regulate maintenance of neural precursor cells in the brain. J Biol Chem. 2003 278 : 44808 15.
15. Ishibashi M. Molecular mechanisms for morphogenesis of the central nervous system in mammals. Anat Sci Int. 2004 79 : 226 34.
16. Louvi A, Artavanis-Tsakonas S. Notch signaling in vertebrate neural development. Nat Rev Neurosci. 2006 7 : 93 102.
17. Kageyama R, Ohtsuka T, Kobayashi T. The Hes gene family: repressors and oscillators that orchestrate embryogenesis. Development. 2007 134 : 1243 51.
18. Androutsellis-Theotokis A, Leker RR, Soldner F, Hoeppner DJ, Ravin R, Poser SW, Rueger MA, Bae SK, Kittapa R, McKay RD. Notch signaling regulates stem cell numbers in vitro and in vivo. Nature. 2006 442 : 823 6.
19. Basak O, Taylor V. Identification of selfreplicating multipotent progenitors in the embryonic nervous system by high Notch activity and Hes5 expression. Eur J Neurosci. 2007 25 : 1006 22.
20. Kanamori M, Kawaguchi T, Nigro JM, Feuerstein BG, Berger MS, Miele L, Pieper RO. Contribution of Notch signaling activation to human glioblastoma multiforme. J Neurosurg. 2007 106 : 417 27.
21. Trimarchi JM, Lees JA. Sibling rivalry in the E2F family. Nat Rev Mol Cell Biol. 2002 3 : 11 20.
22. Zhu L. Tumour suppressor retinoblastoma protein Rb: a transcriptional regulator. Eur J Cancer. 2005 41 : 2415 27.
23. Bracken AP, Ciro M, Cocito A, Helin K. E2F target genes: unraveling the biology. Trends Biochem Sci. 2004 29 : 409 17.
24. Szekely L, Jiang WQ, Bulic-Jakus F, Rosen A, Ringertz N, Klein G, Wiman KG. Cell type and differentiation dependent heterogeneity in retinoblastoma protein expression in SCID mouse fetuses. Cell Growth Differ. 1992 3 : 149 56.
25. Clarke AR, Maandag ER, van Roon M, Van Der Lugt NM, Van Der Valk M, Hooper ML, Berns A, te Riele H. Requirement for a functional Rb-1 gene in murine development. Nature 1992 359 : 328 30.
26. Jacks T, Fazeli A, Schmitt EM, Bronson RT, Goodell MA, Weinberg RA. Effects of an Rb mutation in the mouse. Nature. 1992 359 : 295 300.
27. Lee EY, Chang CY, Hu N, Wang YC, Lai CC, Herrup K, Lee WH, Bradley A. Mice deficient for Rb are nonviable and show defects in neurogenesis and haematopoiesis. Nature. 1992 359 : 288 94.
28. Lee EY, Hu N, Yuan SS, Cox LA, Bradley A, Lee WH, Herrup K. Dual roles of the retinoblastoma protein in cell cycle regulation and neuron differentiation. Genes Dev. 1994 8 : 2008 21.
29. Callaghan DA, Dong L, Callaghan SM, Hou YX, Dagnino L, Slack RS. Neural precursor cells differentiating in the absence of Rb exhibit delayed terminal mitosis and deregulated E2F1 and 3 activity. Dev Biol. 1999 207 : 257 70.
30. Lipinski MM, Macleod KF, Williams BO, Mullany TL, Crowly D, Jacks T. Cellautonomous and non-cell-autonomous functions of the Rb tumor suppressor in developing central nervous system. EMBO J. 2001 20 : 3402 13.
31. Ferguson KL, Vanderluit JL, Hébert JM, McIntosh WC, Tibbo E, MacLaurin JG, Park DS, Wallace VA, Vooijs M, McConnell SK, Slacks RS. Telencephalonspecific Rb knockouts reveal enhanced neurogenesis, survival and abnormal cortical development. EMBO J. 2002 21 : 3337 46.
32. MacPherson D, Sage J, Crowley D, Trumpp A, Bronson RT, Jacks T. Conditional mutation of Rb causes cell cycle defects without apoptosis in the central nervous system. Mol Cell Biol. 2003 23 : 1044 53.
33. Classon M, Harlow E. The retinoblastoma tumour suppressor in development and cancer. Nat Rev Cancer. 2002 910 : 910 7.
34. Alonso MM, Fueyo J, Shay JW, Aldape KD, Jiang H, Lee OH, Johnson DG, Xu J, Kondo Y, Kanzawa T, Kyo S, Bekele BN, Zhou X, Nigro J, McDonald JM, Yung WK, Gomez-Manzano C. Expression of transcription factor E2F1 and telomerase in glioblastomas: mechanistic linkage and prognostic significance. J Natl Cancer Inst. 2005 97 : 1589 600.
35. Blum R, Nakdimon I, Goldberg L, Elkon R, Shamir R, Rechavi G, Kloog Y. E2F identified by promoter and biochemical analysis as a central target of glioblastoma cell-cycle arrest in response to Ras inhibition. Int J Cancer. 2006 119 : 527 38.
36. rd ed. Totowa, NJ : Humana Press 2001. pp. 173 7.
37. Vigo E, Müller H, Prosperini E, Hateboer G, Cartwright P, Moroni MC, Helin K. Cdc25A phosphatase is a target of E2F and is required for efficient E2F-induced S phase. Mol Cell Biol. 1999 19 : 6379 95.
38. Müller H, Bracken AP, Vernell R, Moroni MC, Christians F, Grassilli E, Prosperini E, Vigo E, Oliner JD, Helin K. E2Fs regulate the expression of genes involved in differentiation, development, proliferation and apoptosis. Genes Dev. 2001 15 : 267 85.
39. Frank SR, Schroeder M, Fernandez P, Taubert S, Amati B. Binding of c-Myc to chromatin mediates mitogen-induced acetylation of histone H4 and gene activation. Genes Dev. 2001 15 : 2069 82.
40. Kononen J, Bubendorf L, Kallioniemi A, Bärlund M, Schraml P, Leighton S, Torhorst J, Mihatsch MJ, Sauter G, Kallioniemi OP. Tissue microarrays for high-throughput molecular profiling of tumor specimens. Nat Med. 1998 4 : 844 7.
41. Rugarli EI, Lutz B, Kuratani SC, Wawersik S, Borsani G, Ballabio A, Eichele G. Expression pattern of the Kallmann syndrome gene in the olfactory system suggests a role in neuronal targeting. Nat Genet. 1993 4 : 19 26.
42. Nakagawa O, McFadden DG, Nagakawa M, Yanagisawa H, Hu T, Srivastava D, Olson EN. Members of the HRT family of basic helix-loop-helix proteins act as transcriptional repressors downstream of Notch signaling. Proc Natl Acad Sci USA. 2000 97 : 13655 60.
43. Iso T, Sartorelli V, Chung G, Shichinohe T, Kedes L, Hamamori Y. HERP, a new primary target of Notch regulated by ligand binding. Mol Cell Biol. 2001 21 : 6071 9.
44. Moroni MC, Hickman ES, Lazzerini Denchi E, Caprara G, Colli E, Cecconi F, Müller H, Helin K. Apaf-1 is a transcriptional target for E2F and p53. Nat Cell Biol. 2001 3 : 552 8.
45. Maier MM, Gessler M. Comparative analysis of the human and mouse Hey1 promoter: Hey genes are new Notch target genes. Biochem Biophys Res Commun. 2000 275 : 652 60.
46. Pece S, Serresi M, Santolini E, Capra M, Hulleman E, Galimberti V, Zurrida S, Maisonneuve P, Viale G, DiFiore PP. Loss of negative regulation by Numb over Notch is relevant to human breast carcinogenesis. J Cell Biol. 2004 167 : 215 21.
47. Sjölund J, Manetopoulos C, Stockhausen M-T, Axelson H. The Notch pathway in cancer: differentiation gone awry. Eur J Cancer. 2005 41 : 2620 9.
48. Jennings B, Preiss A, Delidakis C, Bray S. The Notch signaling pathway is required for Enhancer of split bHLH protein expression during neurogenesis in the Drosophila embryo. Development. 1994 120 : 3537 48.
49. Baily AM, Posakony JW. Suppressor of hairless directly activates transcription of enhancer of split complex genes in response to Notch receptor activity. Genes Dev. 1995 9 : 2609 22.
50. Yoon K. Gaiano N. Notch signaling in the mammalian central nervous system: insights from mouse mutants. Nat Neurosci. 2005 8 : 709 15.
51. Purow BW, Haque RM, Noel MW, Su Q, Burdick MJ, Lee J, Sundaresan T, Pastorino S, Park JK, Mikolaenko I, Maric D, Eberhart CG, Fine HA. Expression of Notch-1 and its ligands, Delta-like-1 and Jagged-1, is critical for glioma cell survival and proliferation. Cancer Res. 2005 65 : 2353 63.
52. Phillips HS, Kharbanda S, Chen R, Forrest WF, Soriano RH, Wu TD, Misra A, Nigro JM, Colman H, Soroceanu L, Williams PM, Modrusan Z, Feuerstein BG, Aldape K. Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis. Cancer Cell. 2006 9 : 157 73.
53. Shih AH, Holland EC. Notch signaling enhances nestin expression in gliomas. Neoplasia. 2006 8 : 1072 82.
54. Chiba S. Notch signaling in stem cell systems. Stem Cells. 2006 24 : 2437 47.
55. Warr T, Ward S, Burrows J, Harding B, Wilkins P, Harkness W, Hayward R, Darling J, Thomas D. Identification of extensive genomic loss and gain by comparative genomic hybridization in malignant astrocytoma in children and young adults. Genes Chromosomes Cancer. 2007 31 : 15 22.
56. Shiras A, Chettiar S, Shepal V, Rajendran G, Prasad GR, Shastry P. Spontaneous transformation of human adult non-tumorigenic stem cells to cancer stem cells is driven by genomic instability in a human model of glioblastoma. Stem Cells. 2007 25 : 1478 89.
57. Sundaram, MV. The love-hate relationship between Ras and Notch. Genes Dev. 2005 19 : 1825 39.